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Abstract. 
 
Ectopic expression of various members of 
the human carcinoembryonic antigen (CEA) family
of intercellular adhesion molecules in murine myo-
blasts either blocks (CEA, CEACAM6) or allows 
(CEACAM1) myogenic differentiation. These surface 
glycoproteins form a subset of the immunoglobulin (Ig) 
superfamily and are very closely related, but differ in 
the precise sequence of their external domains and in 
their mode of anchorage to the cell membrane. CEA 
and CEACAM6 are glycophosphatidyl-inositol (GPI) 
anchored, whereas CEACAM1 is transmembrane 
(TM) anchored. Overexpression of GPI-linked neural 
cell adhesion molecule (NCAM) p125, also an adhesion 
molecule of the Ig superfamily, accelerates myogenic 
differentiation. The molecular requirements for the 
myogenic differentiation block were investigated using 
chimeric constructs in which the COOH-terminal hy-
drophobic domains of CEA, CEACAM1, and NCAM 
p125 were exchanged. The presence of the GPI signal 
sequence speciﬁcally from CEA in the chimeras was 
sufﬁcient to convert both CEACAM1 and NCAM into 
differentiation-blocking proteins. Conversely, CEA 
could be converted into a neutral protein by exchang-
ing its GPI anchor for the TM anchor of CEACAM1. 
Since the external domains of CEA, CEACAM1, and 
NCAM can all undergo homophilic interactions, and 
mutations in the self-adhesive domains of CEA abro-
gate its differentiation-blocking activity, the structural 
requirements for differentiation-inhibition are any self-
adhesive domains attached to the speciﬁc GPI anchor 
derived from CEA. We therefore suggest that biologi-
cally signiﬁcant functional information resides in the 
processed extreme COOH terminus of CEA and in the 
GPI anchor that it determines.
Key words: CEA • GPI anchors • inhibition of differ-
entiation • Ig superfamily • NCAM
 
Introduction
 
Carcinoembryonic antigen (CEA)
 
1
 
 is overexpressed in
many human cancers, including those of colorectal, breast,
and lung origins, and for 30 yr has been one of the most
prevalent tumor markers (Averbach and Sugarbaker,
1995; Boucher et al., 1989; Ilantzis et al., 1997). CEA is the
prototypic member of a large gene subfamily (Öbrink,
1997) of the Ig superfamily that includes CEACAM1
(formerly BGP) and CEACAM6 (formerly NCA).
CEACAM6, like CEA, is upregulated in human malig-
nancy (Boucher et al., 1989; Hinoda et al., 1991; Ilantzis
et al., 1997; Kim et al., 1992), whereas CEACAM1 is usu-
ally downregulated, suggesting that CEACAM1 could act
as a tumor suppressor, as has been shown for the mouse
and rat homologues of human CEACAM1 (Hsieh et al.,
1995; Kleinerman et al., 1995; Kunath et al., 1995; Neu-
maier et al., 1993). CEA, CEACAM6, and CEACAM1 all
possess homotypic intercellular adhesion activity in vitro
(Benchimol et al., 1989; Oikawa et al., 1989; Rojas et al.,
1990; Zhou et al., 1990). CEA and CEACAM6 are gly-
cophosphatidyl-inositol (GPI)-linked to the cell surface
(Hefta et al., 1988, 1990; Takami et al., 1988), whereas
CEACAM1 has transmembrane (TM) and cytoplasmic
domains, features that correlate with observed differences
in function to date (Rojas et al., 1996).
Myogenic fusion requires the functional integrity of
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cell–cell adhesion systems, such as the cadherins (N-cad-
herin, M-cadherin) and Ig superfamily adhesion molecules
(NCAM, vascular [V]CAM), and cell–ECM-binding inter-
actions mediated by the integrin family, which includes
VLA-4/
 
a
 
4
 
b
 
1
 
 and 
 
a
 
5
 
b
 
1
 
 (Knudsen, 1990). Overexpression of
various splice variants of human NCAM accelerates myo-
genesis in mouse C2 myoblasts (Peck and Walsh, 1993;
Dickson et al., 1990) and in transgenic mice (Fazeli et al.,
1996). These include the p125 isoform, which possesses
five Ig C2-like repeats, two partial non-RGD fibronectin
type III–like domains, a 5-kD skeletal muscle-specific do-
main (Dickson et al., 1987), and a GPI anchor (Barton et
al., 1988). We have demonstrated that ectopic expression
of CEA and CEACAM6 disrupts the differentiation pro-
gram of rat L6 myoblasts, whereas CEACAM1 and an ad-
hesion-defective deletion mutant of CEA (
 
D
 
NCEA) were
unable to inhibit differentiation (Eidelman et al., 1993;
Rojas et al., 1996). These results are consistent with the
observed upregulation of CEA and CEACAM6 and down-
regulation of CEACAM1 in human tumors. Moreover,
CEA significantly reduces the latency required to form tu-
mors in nude mice, and cooperates with Myc and Bcl-2 in
transformation; we have proposed that CEA’s differentia-
tion-blocking activity represents a novel contribution to
oncogenesis (Screaton et al., 1997).
GPI proteins are specifically targeted to apical mem-
branes and excluded from the basolateral membranes of
polarized epithelial cells (Rodriguez-Boulan and Nelson,
1989). Conversely, proteins with a bona fide TM domain
are generally transported to basolateral surfaces, by virtue
of signals in their cytoplasmic domains. The lateral com-
partmentalization of GPI proteins within the lipid bilayer
is initiated during membrane biosynthesis, and results not
from protein–protein interactions, but from the preferen-
tial miscibility of the glycolipid moiety of the GPI anchor
with sphingolipids and cholesterol, perhaps together with
the lectin VIP36 (Fiedler and Simons, 1996; Simons and
Ikonen, 1997). These three components coalesce in the
trans-Golgi network to form membrane islands, or rafts,
which serve as targeting shuttles to the apical surface (Si-
mons and Ikonen, 1997). Rafts can be concentrated in
vitro at 4
 
8
 
C as a precipitate of nonionic, detergent-insolu-
ble glycolipid domains, or DIGs, a low-density membrane
fraction rich in unsaturated glycolipids and GPI proteins
(Brown and London, 1997; Brown and Rose, 1992; Fiedler
et al., 1993). Interestingly, rafts are also involved in target-
ing of apical markers in nonpolarized cells (Musch et al.,
1996; Yoshimori et al., 1996); however, in the absence of
epithelial tight junctions, raft components diffuse to ho-
mogeneity once at the cell surface. Apart from GPI pro-
teins, DIGs concentrate doubly acylated tyrosine kinases
of the src family (Dráberova and Dráber, 1993; Rodgers
et al., 1994; Shenoy-Scaria et al., 1992, 1993, 1994), which
are tethered to the inner cytoplasmic leaflet of the mem-
brane bilayer by covalent myristoyl and palmitoyl group
modifications, and G
 
a
 
 monomers (Solomon et al., 1996).
Thus the interaction of GPI proteins with the lipid constit-
uents of rafts at the plasma membrane govern their local-
ization and possibly their functions at the cell surface.
Recently, the existence of rafts under physiological condi-
tions in fibroblasts and epithelial cells has been demon-
strated using fluorescence resonance energy transfer and
chemical cross-linking techniques, respectively (Frieder-
ichson and Kurzchalia, 1998; Varma and Mayor, 1998).
We have addressed the role of the external domains and
the GPI anchor in the CEA-mediated myogenic differenti-
ation block using chimeras between CEA, CEACAM1,
and GPI-linked NCAM p125. We confirm that overex-
pression of NCAM accelerates myogenesis (Peck and
Walsh, 1993), and report that the CEA, CEACAM1, or
NCAM extracellular domains are sufficient to inhibit dif-
ferentiation when attached specifically to a CEA GPI an-
chor. Conversely, replacing the GPI linkage of CEA with
the TM domain of CEACAM1 cancels the differentiation
block. These results lead to the following hypothesis: the
differentiation inhibition activity of CEA requires the
combination of CEA GPI linkage with any functional ex-
ternal self-adhesion domain. Since the COOH-terminal
domain of CEA and not that of NCAM is necessary for
the block, the GPI anchors that replace these domains har-
bor specific biological information.
 
Materials and Methods
 
Cell Culture and Differentiation Assay
 
CHO-derived LR-73 fibroblasts (Pollard and Stanners, 1979) were grown
in monolayer in 
 
a
 
-MEM plus 10% FBS in a humidified atmosphere of 5%
CO
 
2
 
 at 37
 
8
 
C. Rat L6 (Yaffe, 1968) myoblasts were grown as monolayer
cultures in DME containing 10% FBS (growth medium) as previously de-
scribed (Screaton et al., 1997). All myoblast cultures were passaged while
subconfluent to avoid selection of nonfusing variants. The differentiation/
fusion assay was performed in DME plus 2% horse serum (differentiation
medium) as previously described (Screaton et al., 1997); cultures were as-
sessed for fusion after 4 d in differentiation medium.
 
Constructs
 
The CEACAM1–CEA (C1–C) chimera (Dráber, P., and C.P. Stanners,
unpublished data) possesses the leader, N, A1B1, and A2 domains of
CEACAM1 and six extracellular residues plus the hydrophobic COOH-
terminal domain of CEA. C1–C was produced by ligation of nucleotides
(nt) 1–1314 of CEACAM1-4L (the longest splice variant of CEACAM1,
denoted C1-4L in Fig. 9 and with the basic structure shown therein) to nt
2106–3037 of CEA at HindIII sites introduced into both cDNAs at the
specified positions. The C–C1S chimera consists of the external domains
of CEA linked to the TM and short cytoplasmic domains of the
CEACAM1 splice variant, CEACAM1-1S; this chimera was generated by
PCR overlap extension modeled after Sippel et al. (1996), as follows: a
first round of PCR was performed using: (i) the CEA cDNA and 5
 
9
 
 out-
side primer 5
 
9
 
 TAGTGGATCCTATACGTGCCAA 3
 
9
 
 (nt 975–996, con-
taining the underlined natural BamHI site) and internal antisense primer
5
 
9
 
 TGAGAGGCCATTTTCGACTGTGATGCTCTTGACTA 3
 
9
 
 (corre-
sponds to nt 992–1006 of CEACAM1-1S at the 5
 
9
 
 end and nt 2099–2018 of
CEA at the 3
 
9
 
 end) to produce a 1.1-kb product, and (ii) the CEACAM1-
1S cDNA and 3
 
9
 
 outside primer 5
 
9
 
 ATGAATTCATAAATTATTTCT-
GTGGC 3
 
9
 
 (nt 1218–1235, with the underlined added EcoRI site) and 5
 
9
 
sense internal primer 5
 
9
 
 AAGAGCATCACAGTCGAAAATGGC-
CTCTCA 3
 
9
 
 (antisense of the internal primer used in i, minus 5 nt at 5
 
9
 
end) to produce a 0.3-kb product. A second round of PCR using the 1.1-
and 0.3-kb round 1 products and the two outside primers listed above pro-
duced a 1.4-kb product, which was digested with BamHI (5
 
9
 
 end) and
EcoRI (3
 
9
 
 end) and ligated to the 5
 
9
 
 end of the BamH1-digested CEA
cDNA to produce C–C1S.
N–C and C–N were generated using overlap extension as follows: as the
 
v
 
-site in NCAM is unknown, we assigned it to be the last amino acid
(A736) encoded by exon 14; thus the TM domain in NCAM begins at
Thr737. Exon 14 is spliced onto the GPI-specific exon 16 in the p125 splice
variant (Barton et al., 1988). Sequence alignment supports this as a possi-
ble 
 
v
 
-site (Udenfriend and Kodukula, 1995; Moran et al., 1991; Nuoffer et al.,
1993). Other possible sites (Gly739, Gly740, Asn741, and Ser742) were ex-
cluded on the basis of nonconservation between chickens and humans: in 
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chicken NCAM, Gly740, Asn741, and Ser742 are Ser740, Pro741, and
Ser742 (see Fig. 1). The presence of a proline residue at position 742 in
chicken makes GPI substitution at these positions unlikely, if not impossi-
ble. The junction site between NCAM and CEA was selected to be six res-
idues from the beginning of the TM domain, as for C1–C. For N–C, PCR
was performed with the 5
 
9
 
 primer 5
 
9
 
 GCAGTGACCACGTCATGC 3
 
9
 
(nt 2214–2231 of NCAM, containing a natural AspI site, underlined),
and 3
 
9
 
 primer 5
 
9
 
 TGAAGCTTGGCTGGGCCGAGG 3
 
9
 
 (nt 2327–2339
NCAM 125), with an added HindIII site (underlined). After digestion
with AspI and HindIII, this 0.13-kb fragment was ligated together with
2.2-kb SalI–AspI NCAM and 0.9-kb HindIII–EcoRI CEA fragments in
one reaction into pBluescript (Stratagene). For N–C blunt, a first round of
two PCR reactions was performed using CEA or NCAM template cDNA.
For the NCAM template, the 5
 
9
 
 outside primer was 5
 
9
 
 GCAGTGAC-
CACGTCATGC 3
 
9
 
 (nt 2214–2231 of NCAM containing a natural AspI
site, underlined), and for CEA the 3
 
9
 
 antisense outside primer was 5
 
9
 
CTAGAACTAGTGGATCCC 3
 
9
 
 (sequence from pBluescript MCS con-
taining a BamHI site, underlined). The inside primers were 5
 
9
 
 AGG-
AGAAGTTCCAGATGCTGGGATGGCTGTGGG 3
 
9
 
 and 5
 
9
 
 ACAG-
CCATCCCAGCATCTGGAACTTCTCCTGGTC 3
 
9
 
 (nt 2191–2223 of
NCAM and nt 2014–2047 of CEA in both the antisense and sense direc-
tions, respectively). The second round of PCR used the two first round
products, as described above for C–C1S. The final PCR product was di-
gested with AspI and BamHI, and was cloned into pBluescript (N–C) at
the corresponding AspI and BamHI sites, thus removing the fragment
containing the HindIII site junction. All constructs were subcloned into
the p91023B expression vector (courtesy of R. Kaufman, Genetics Insti-
tute, Boston, MA) for transfection.
 
Transfections
 
L6 myoblasts and LR-73 fibroblasts were seeded at 1.8 
 
3
 
 10
 
5
 
, or 4 and 6 
 
3
 
10
 
5
 
 cells/100-mm dish, respectively, and cotransfected 24 h later by cal-
cium phosphate coprecipitation with 5 
 
m
 
g of p91023B expression vector
containing appropriate cDNA chimeras and 0.5 
 
m
 
g pSV2neo or
pBabe(neo) plasmid per dish. For human NCAM-125 (a kind gift of F.S.
Walsh, ICRF, London, UK), 5 
 
m
 
g p4.4.4(NCAM)-neo expression vector
(Gunning et al., 1987) was used. Neomycin(G418)-resistant pooled trans-
fectant populations were selected with 400–600 
 
m
 
g/ml G418 for 12–14 d.
G418-resistant clones were isolated either individually, or pooled and
sorted for high surface expression levels by FACS using monoclonal anti-
CEA antibody (J22; Zhou et al., 1993) or monoclonal anti–human NCAM
antibody (ERIC-1; BIOCAN Scientific). Double transfectant total popu-
lations were generated either by cotransfection of NCAM 125 cDNA with
pBabe(hygro) into L6(CEA) cells, followed by selection with 100 
 
m
 
g/ml
hygromycin-B, or by cotransfection of both cDNAs together with
pBabe(neo) into parental L6 myoblasts, followed by selection with G418
as described above. Two independent transfections were done for C1–C,
N–C blunt, and CEA, with identical results in assays for biological effects.
All other transfections were carried out once. To avoid difficulties in in-
terpretation due to clonal differences in cellular properties unrelated to
those caused by the transfected construct, populations of pooled transfec-
tant clones were used in all cases, except clones L6(CEACAM1–4L), de-
noted L6(C1–4L) here; LR(CEACAM1–4L), denoted LR(C1–4L) here;
L6(CEACAM6); and LR(CEA-7), which were all used as positive con-
trols here and have been shown previously to be representative in cellular
properties (Rojas et al., 1990, 1996); for L6(C–C1S), two independent
clones were tested, which gave equivalent results. The LR-73 pooled
transfectant populations were comprised of hundreds of clones, whereas
the L6 pooled transfectant populations consisted of 20–50 clones; the
polyclonal nature of the latter was confirmed by Southern analysis indicat-
ing multiple integration sites, as described elsewhere for the L6(CEA)
pooled transfectant population (Screaton et al., 1997). All functional as-
says were performed in the absence of G418 selection, and no loss of sur-
face expression was detected over the culture period required for the as-
says (data not shown).
 
FACS Analysis
 
Exponentially growing cultures were trypsinized (CEA family transfec-
tants) or incubated with PBS-citrate plus 4 mM EDTA (PBS-C-E)
(NCAM p125 transfectants) for 3–4 min at 37
 
8
 
C. NCAM is sensitive to
trypsin, which removes a major 50-kD NCAM fragment (estimated from
SDS-PAGE mobility), reducing overall NCAM surface levels two to
threefold (data not shown). 1.25 
 
3
 
 10
 
5
 
 cells were resuspended in 0.25 ml
 
ice cold PBS plus 2% FBS (PBSF) containing mAbs J22 or ERIC-1 at a
dilution of 1:50 to 1:100 for 30 min on ice. Cells were centrifuged, rinsed
with 2 ml PBSF, and resuspended in 0.25 ml PBSF containing goat anti–
mouse FITC- or phycoerythrin-conjugated antibody (BIOCAN Scientific)
diluted 1:100. After 30 min of incubation, cells were rinsed and resus-
pended in 0.3 ml PBSF for cytofluorometric analysis using a FACScan™
instrument (Becton Dickinson).
 
Triton X-100 Solubility Assay and Immunoblotting
 
Exponentially growing cultures were rinsed with PBS and rendered single
cell suspensions by incubating with PBS-C-E for 4 min at 37
 
8
 
C, followed
by passing once through a 27-gauge needle. Cell concentrations were de-
termined using a particle counter (Coulter Electronics, Inc.). Cell popula-
tions were resuspended at 10
 
7
 
 cells/ml in ice cold lysis buffer (20 mM Tris,
pH 8.0, 150 mM NaCl, and 2.5 mM EDTA plus protease inhibitors) con-
taining 1% Triton X-100 (Sigma-Aldrich). Cells were syringed with 10 up
and down strokes using a 27-gauge needle, and left at 0
 
8
 
C for 15 min. Sol-
uble fractions were collected after 20 min of centrifugation at 13,500 
 
g
 
 at
4
 
8
 
C. The pellets were resuspended in 0.9-vol lysis buffer without Triton
X-100 and syringed 5 times at 0
 
8
 
C with a 23-gauge needle. 0.1 vol 10%
SDS was added (equivalent cell concentration: 10
 
7
 
/ml) before syringing 5
times with a 23-gauge needle, then 10 times with a 27-gauge needle (pellet
fraction). Lysates of soluble and pellet fractions were normalized to cell
surface expression level (from 10
 
3
 
 [NCAM] to 2 
 
3 
 
10
 
5
 
 [C1–4L] cell equiv-
alents), resolved by SDS-PAGE, and transferred electrophoretically to a
0.45-
 
m
 
m PVDF membrane (Millipore) for immunoblotting. The following
monoclonal antibodies were used: J22 for CEA, CEACAM6, C–C1S, and
C–N; TEC-11 (Dráberova et al., 1997) for C1–4L and C1–C; and ERIC-1
for NCAM, N–C, and N–C blunt at a dilution of 1:1,000 for 1 h at 25
 
8
 
C in
TBS-Tween 20/M, and processed as previously described (Screaton et al.,
1997). For solubility determinations, increasing volumes of lysates were
separated by SDS-PAGE and transferred to PVDF for immunoblotting.
Multiple timed ECL exposures of each immunoblot were scanned and an-
alyzed with Adobe Photoshop and NIH Image 1.61 software. Solubility
was determined using only values in the linear exposure range.
 
Adherent Cell PI-PLC Assay
 
Cells were seeded at 7 
 
3
 
 10
 
3
 
/cm
 
2
 
 in 24-well plates in GM on day 0. On day
2, exponentially growing cultures were rinsed twice with PBS, and incubated
with 0.03–0.09 U bacterial phosphatidylinositol phospholipase C (PI-PLC;
Boehringer Mannheim) in 1:1 DME/PBS plus 0.2% BSA for 40 min at
37
 
8
 
C. The PI-PLC was removed, cultures were rinsed with PBS and ren-
dered single cell suspensions by trituration after incubation with PBS-C-E at
37
 
8
 
C for 4 min. The cells were then processed for FACS analysis as above.
 
Adhesion Assays
 
Assays were performed essentially as previously described (Zhou et al.,
1993). In brief, 10
 
6
 
 cells of LR73 transfectant cultures were seeded in 80-
cm
 
2
 
 culture flasks (Nunc) on day 0. On day 2, cells (CEA family transfec-
tants) were harvested with BACTO-Trypsin (GIBCO BRL) for 3 min at
37
 
8
 
C or with PBS-C-E (N–C blunt). The cell suspensions were syringed up
and down once through a 27-gauge needle before cell counting. 3 
 
3
 
 10
 
6
 
cells were resuspended in 3 ml of 
 
a
 
-MEM plus 0.8% FBS plus 10 
 
m
 
g/ml
DNAse I, and allowed to aggregate at 37
 
8
 
C with stirring at 100 rpm. Ali-
quots were taken at the indicated time points and the percentage of single
cells was determined visually in a hemocytometer.
 
Colocalization Assay
 
7 
 
3
 
 10
 
3
 
 cells were seeded in 8-well chamber slides (Nunc) on day 0. On
day 2, cells were rinsed with PBS and fixed with 4% paraformaldehyde for
20 min at room temperature before placing on ice, or else rinsed and
placed on ice immediately to inhibit cellular metabolism and GPI protein
mobility. Nonspecific antibody interactions were blocked with DME plus
5% goat serum (DG5) for 20 min before antibody addition. All antibody
incubations were carried out for 30 min on ice, followed by 3 
 
3
 
 5 min
rinses with ice-cold DG5. Antibodies and dilutions were as follows: rabbit
polyclonal anti-CEA (1:50), goat anti–rabbit-Cy2 conjugate (1:800),
ERIC-1 (1:10), and goat anti–mouse-rhodamine conjugate (1:200). For
patching, unfixed cells were incubated stepwise with the appropriate pri-
mary and secondary antibody combination to stain the first antigen, rinsed
with DG5, and incubated at 37
 
8
 
C for 60 min to induce patch formation. 
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After patching, the cells were returned to ice for staining of the second an-
tigen, as described above. Cells were fixed with 4% paraformaldehyde for
20 min at room temperature after staining, mounted, and viewed with a
fluorescence microscope (Nikon).
 
Results
 
Synthesis and Characterization of COOH-terminal 
Domain Exchange Constructs
 
To determine the domains involved in the inhibition of
myogenesis by CEA, chimeric constructs were constructed
using CEA and CEACAM1 cDNAs in which the mode of
membrane attachment was exchanged. We replaced the
TM and cytoplasmic domains of CEACAM1–4L (C1–4L)
with the 32 COOH-terminal residues of CEA, which
possesses the CEA 
 
v
 
-site for GPI attachment, Ala677, to
produce C1–C (Fig. 1). The reciprocal chimera, C–C1S,
possesses the complete extracellular domains of CEA at-
tached to the TM and short cytoplasmic domains (43
amino acids total) of the CEACAM1-1S splice variant
(Barnett et al., 1993). The COOH-terminal sequence of
the CEACAM1-1S (C1-1S) splice variant with its short cy-
toplasmic domain of about eight residues was selected for
use in the construction of C–C1S to most closely mimic a
GPI anchor, i.e., a membrane attachment with no intra-
cellular sequence information. Stable pooled transfectant
populations or individual clones of L6 myoblasts (see Ma-
terials and Methods) expressing the chimeras at their sur-
face were isolated, and the FACS profiles for these and all
L6 transfectants used in this study are shown in Fig. 2.
Cell surface proteins that possess a TM domain are solu-
ble in nonionic detergents such as Triton X-100 at 4
 
8
 
C; in-
solubility under these conditions indicates that the protein
may possess a GPI membrane anchor (Brown and Rose,
1992; Hooper and Bashir, 1991; Hooper and Turner,
1988). To determine if the membrane attachment modes
were faithfully exchanged in the chimeras, we investigated
the solubility of the CEA family members and C1–C and
C–C1S in cold Triton X-100 (Fig. 3 A). CEA, CEACAM6,
and C1–C detected by immunoblotting and quantitated by
densitometric analysis were 
 
z
 
10–20% soluble, supporting
their GPI linkage, whereas C1–4L and C–C1S were 
 
.
 
90%
soluble, indicating that they both possess a TM anchor. All
proteins were 
 
.
 
90% soluble in octylglucoside (data not
shown), which extracts GPI-linked proteins from Triton
X-100–insoluble membrane domains (Brown and Rose,
1992). It was possible that, by overexpressing these GPI-
linked proteins, they were saturating the glycosphingolipid
rafts in which they are normally localized. However, we
observed no change in solubility, for CEA at least, over
the range of surface expression found in these transfec-
tants (data not shown). To confirm the presence of a GPI
anchor on the various constructs, we also investigated the
sensitivity of each protein to bacterial PI-PLC, an enzyme
Figure 1. Amino acid sequence alignment of
CEA family members, human (h) NCAM p125,
chicken (C) NCAM p120, and chimeras as
predicted by their cDNA sequences. The pre-
cursor COOH-terminal hydrophobic domains
removed by GPI processing are separated by
a gap from their extracellular sequences. The
amino acid positions given include the leader
domain starting with the initiator methio-
nine residue as No. 1. The v-site for attach-
ment of the GPI anchor, known for CEA and
CEACAM6 and inferred for NCAM p125,
C1–C, N–C, N-C blunt and C–N constructs, is
aligned and denoted by an arrow (see Materi-
als and Methods). The vertical bars represent
construct fusion points, and the positions of
stop codons are given by asterisks. An I to F
mutation created by introduction of a HindIII
site at the chimera junction is underlined. The
long (-L) and short (-S) cytoplasmic domains
of CEACAM1 are denoted by broken under-
lining.
Figure 2. Surface expression
of CEA family members,
NCAM p125, and chimeric
constructs in L6 cell transfec-
tants. FACS profiles showing
levels of surface expression
of (A) CEA pooled popula-
tion, CEACAM6 clone, and
C1–C pooled population; (B)
C1–4L and C–C1S clones;
and (C) NCAM, N-C blunt
and N–C pooled popula-
tions.  All cells were labeled
with monoclonal anti-CEA or
anti–human NCAM antibod-
ies. Immunoreactivity was de-
tected with goat anti–mouse
FITC-conjugated antibody, as
described in Materials and
Methods. 
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that digests the phosphate-glycerol ester linkage of GPI
anchors. Sensitivity of a cell surface molecule to PI-PLC
treatment can be measured as a reduction in its cell sur-
face level by cytofluorometry (Lisanti et al., 1990). We ob-
served that the GPI proteins under investigation had dif-
ferent sensitivities to PI-PLC when treated in monolayer
culture or in suspension after EDTA or trypsin treatment
(data not shown). We therefore chose to treat cells with
PI-PLC in monolayer culture to test their sensitivity in a
physiologically normal state during their growth phase. L6
transfectants were treated with PI-PLC, labeled with ap-
propriate monoclonal antibodies, and analyzed by FACS
(Fig. 3 B). PI-PLC partially removed surface-bound CEA,
C1–C, and CEACAM6, confirming their GPI membrane
attachment, but did not change surface levels of C–C1S (or
CEACAM1, not shown). These results support the con-
clusion that the C1–C chimera is GPI linked, and that
C–C1S possesses a bona fide TM anchor.
 
Chimeric Constructs Retain Homotypic
Adhesion Function
 
Previous results demonstrated a requirement for intact
CEA extracellular adhesion domains to block differentia-
tion (Eidelman et al., 1993). We thus examined the aggre-
gation properties of total transfectant populations of the
nonaggregating CHO fibroblast cell line, LR-73, express-
ing C1–C and C–C1S at their cell surface (Fig. 4 A). Sin-
gle cell suspensions of all transfectants, including the
LR(CEA) and LR(C1–4L) positive controls, aggregated
readily at 37
 
8
 
C (Fig. 4 C). Transfectants with the neo vec-
tor alone did not aggregate appreciably. The extent of ag-
gregation was greater for C1–C than C–C1S (14 vs. 27%
single cells at 2 h), which was probably due to differences
in levels of surface expression (FACS mean fluorescence
values of 600 vs. 200, respectively). Thus, both C1–C and
C–C1S chimeras retained homotypic adhesion function,
indicating self-binding of their extracellular domains, and
could be used to test for the role of the mode of membrane
attachment in inhibiting myogenic differentiation.
 
Effect of Mode of Membrane Attachment on
L6 Differentiation
 
L6 myoblast transfectants were grown to confluence in
growth medium and tested for their ability to differentiate
by incubation in low growth factor–containing differentia-
tion medium. Fig. 5 shows photomicrographs of the cul-
tures after 4 d in differentiation medium, at which time
both the neo control and L6(C1–4L) cultures showed ex-
tensive cell fusion and myotube formation. L6(CEA) cul-
tures, however, consisted of single cells, indicating blocked
cell fusion. Interestingly, L6(C–C1S) cultures formed myo-
tubes, whereas cultures of L6 cells expressing the GPI-
linked C1–C, even at lower cell surface levels than C–C1S
or CEA (Fig. 2), like L6(CEA) remained completely as
single cells (Fig. 5 and Table I). This indicates a direct cor-
relation between GPI anchorage of CEA and differentia-
tion-blocking ability.
 
Effect of Type of GPI Anchor on Adhesion
and Differentiation
 
To confirm the specificity requirements of the extracellu-
lar adhesive domains and to test for the necessity of the
CEA GPI anchor, chimeric constructs between CEA and
the p125 GPI anchored isoform of the more distantly re-
lated Ig family member, NCAM, were generated. The
COOH-terminal hydrophobic domains and six extracellu-
lar amino acids of CEA (as in C1–C) and NCAM were ex-
changed, to produce N–C and C–N. A construct, N–C
blunt, with no extracellular residues from CEA, was also
prepared (Fig. 1). Stable pooled transfectant populations
Figure 3. The COOH-terminal domain of CEA confers cold Tri-
ton X-100 insolubility and PI-PLC sensitivity on hybrid con-
structs expressed in L6 transfectants. (A) Soluble supernatant (S)
and insoluble pellet (P) fractions of cold Triton X-100 lysates
were analyzed by immunoblotting of SDS-PAGE gels. Lysate
volumes for each transfectant were normalized to provide an
equivalent aggregate densitometric value from soluble and insol-
uble fractions. All exposures were within the linear range. (B)
Sensitivity of cell surface CEA, CEACAM6 (positive controls),
C1–C, and C–C1S to PI-PLC (1) or no treatment (2), including
vector only controls (neo), as assessed by FACS analysis.
 
Table I. Differentiation of L6 Transfectants
 
Cell % Fusion*
 
L6(neo) 70
L6(CEA) 0
L6(C1–4L) 84
L6(C–C1S) 60
L6(C1–C) 0
L6(NCAM) 100
L6(NC) 0
L6(NC blunt) 0
 
*Fusion indices provide a measure of myogenic differentation and were measured as
the % of total cells having three or more nuclei, as described previously (Eidelman et
al., 1993). 
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of L6 myoblasts expressing cell surface NCAM and N–C
(Fig. 2) and of L6 and LR-73 cells expressing N–C blunt
(Figs. 2 and 6) were isolated. No clones showing cell sur-
face expression transfected with the C–N cDNA could be
isolated; Western blot analysis and immunofluorescence
data demonstrated that the C–N protein was synthesized
but accumulated in the ER compartment (data not
shown). NCAM, N–C, and N–C blunt were mainly insolu-
ble in cold Triton X-100 (Fig. 6, upper left, 
 
z
 
25% soluble),
and sensitive to PI-PLC (Fig. 6), indicating a GPI mem-
brane attachment. Therefore, cold Triton X-100 solubility
and PI-PLC treatment do not distinguish biochemically
between the GPI membrane anchors of CEA and NCAM.
The adhesion domain of human NCAM has been nar-
rowed to a decapeptide sequence, residues 243–252, present
in the third Ig domain, similar to chicken NCAM (Rao et
al., 1992; Siu, C.-H., personal communication). We veri-
fied that NCAM extracellular sequences retain homotypic
adhesion ability when linked to the cell membrane with a
CEA GPI anchor by performing an aggregation assay, us-
ing LR-73(N–C blunt) cells together with neo (vector alone)
and CEACAM1–4L as negative and positive controls, re-
spectively. Fig. 4 D shows that N–C blunt mediated aggre-
gation of LR fibroblasts efficiently under these conditions
(8% single cells at 2 h), indicating that the presence of
NCAM Ig domains are sufficient to mediate homotypic
adhesion in the chimera.
L6(NCAM), L6(N–C), and L6(N–C blunt) myoblasts were
tested for their ability to differentiate by fusion into myo-
tubes in differentiation medium (Fig. 7 and Table I).
L6(neo) and L6(NCAM) cells differentiated readily, with
a moderate increase in the rate of L6(NCAM) fusion (data
not shown). However, L6(N–C) and L6(N–C blunt), like
L6(CEA) cultures, were completely blocked in their abil-
ity to differentiate, forming no myotubes whatsoever (Ta-
ble I). The cell surface expression levels of N–C blunt and
N–C bracket those of CEA and both are lower than that of
NCAM (Fig. 2), so that the differentiation-inhibitory ef-
fects of the CEA GPI anchor cannot be ascribed to higher
expression levels of the hybrid constructs. These results
Figure 4. C–C1S and C1–C retain homotypic adhesion function, and NCAM sequences confer homotypic adhesion ability to N–C
blunt. (A and B) FACS profiles showing cell surface expression of CEA family members and chimeras in LR73 control cells (neo) and
LR73 transfectant cells. (C) Adhesion assay for LR73 control (neo) and transfectant populations by the kinetics of aggregation in sus-
pension. (D) Adhesion assay for LR(N–C blunt) transfectants, harvested with EDTA to avoid proteolysis by trypsin of NCAM se-
quence, together with neo and C1–4L controls. C–C1S, C1–C, and N–C blunt were pooled transfectant populations, whereas the CEA
and C1–4L positive controls were representative clones. 
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confirm that ectopic expression of GPI-linked p125 can ac-
celerate myoblast fusion (Dickson et al., 1990), and dem-
onstrate that NCAM or C1–4L extracellular domains can
substitute for those of CEA, and can block fusion, pro-
vided they are linked to a CEA-derived GPI anchor. Thus,
the specificity of the differentiation block resides in the ex-
treme COOH terminus of CEA.
 
Cell Surface Distribution of GPI-linked NCAM
and CEA
 
We hypothesized that CEA and NCAM p125, which al-
though both GPI-linked exert opposite phenotypic ef-
fects on L6 differentiation, could be distributed differently
on the surface of L6 myoblasts as a manifestation of their
presumably different GPI anchors. Such a differential dis-
tribution might influence their respective molecular inter-
actions, and explain their different biological effects.
Therefore, we analyzed the cell surface distribution of
CEA and NCAM for overlapping localization in trans-
fectant cells expressing both CEA and NCAM, L6
(CEA
 
1
 
NCAM). In cells fixed with paraformaldehyde be-
fore labeling with fluorescent antibodies, both CEA and
NCAM showed diffuse, finely punctate staining through-
out the cell surface (Fig. 8, a and b), in agreement with
previous analyses (Fujimoto, 1996; Mayor and Maxfield,
1995; Harder et al., 1998). Areas of segregation of the two
antigens were easily discernible, which suggested that the
antigens were not colocalized. To clarify this question, we
cross-linked CEA and NCAM one at a time in unfixed
L6(CEA 
 
1
 
 NCAM) cells at 37
 
8
 
C with specific antibodies
to consolidate their fluorescent signals into patches, and
looked for areas of overlap after patching. If there were no
association between the two proteins sufficient to result
in colocalization, the steady-state distribution of NCAM
should be unaffected by the patching of CEA, and vice
versa. After using anti-CEA antibody to cross-link CEA,
the CEA fluorescence pattern was no longer diffuse, but
concentrated in patches (Fig. 8 c). However, the distribu-
tion of NCAM was diffuse and different after patching of
CEA (Fig. 8 d). Similar results were seen when the recip-
rocal experiment was performed (NCAM patched, CEA
Figure 5. The presence of the GPI anchor–determining COOH-terminal domain of CEA in chimeric constructs is sufficient to inhibit
differentiation. Photomicrographs of neo, C1–4L, CEA, C–C1S, and C1–C cultures incubated for 4 d in differentiation medium. C1–4L,
with a TM domain, has no effect on differentiation; replacing its TM region with the hydrophobic GPI signal sequence from CEA (C1–C)
generates a differentiation-inhibiting protein. Conversely, removing the CEA GPI anchor and replacing it with the TM and cytoplasmic
sequences of the short-tail C1–1S isoform abrogates CEA’s differentiation-blocking activity. 
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unpatched; Fig. 8, e and f). Although patching of one anti-
gen is insufficient to induce copatching of the second, it is
possible that both CEA and NCAM are present in the
same rafts, but in separate lipid environments within these
rafts, which themselves are only weakly associated. This ca-
veat notwithstanding, we conclude that CEA and NCAM
are present in different raft domains. This is consistent
with their radically different biological effects.
 
Discussion
 
Previous work on the structural requirements for the inhi-
bition of myogenic differentiation by CEA showed the ne-
cessity of self interaction of the extracellular domains (Ei-
delman et al., 1993). A GPI-linked adhesion-defective
mutant of CEA (
 
D
 
NCEA), lacking a large portion of the
N domain, did not block differentiation, and the addition
of soluble peptides corresponding to the CEA adhesion
domains restored myogenic fusion in L6(CEA) cells.
Moreover, recent work has shown that single amino acid
substitutions in the N domain that affect the adhesion
function can abrogate the differentiation blocking activity
(Taheri et al., 2000). We subsequently demonstrated
that, although both CEACAM6 and all CEACAM1 splice
variants also mediate cell aggregation, only GPI-linked
CEACAM6, like CEA, could block differentiation, whereas
all of the TM-linked CEACAM1 isoforms could not (Ro-
jas et al., 1996). These observations prompted the current
investigation of the specific structural features of CEA re-
quired to inhibit myogenic differentiation.
 
The L6 Myoblast System
 
The adequacy of the experimentally convenient L6 myo-
blast differentiation system as a test system having biologi-
cal relevance deserves comment. The effects of CEA on L6
myoblasts have also been observed in other cellular systems.
Thus, CEA disrupts adipogenic differentiation (C3H10T1/2
and 3T3L1 fibroblasts) and neurogenic differentiation (ret-
inoic acid–treated P19 EC cells), and deregulate overex-
pression (i.e., before polarization and crypt-like formation)
both of CEA and CEACAM6 inhibits colonocyte polar-
ization and tissue architecture in vitro and in vivo (De-
Marte, L., and C.P. Stanners, unpublished results; Ilantzis,
C., L. DeMarte, R.A. Screaton, and C.P. Stanners, manu-
script submitted for publication; Malette, B., and C.P.
Stanners, manuscript submitted for publication); in addi-
tion, anoikis, an apoptotic mechanism of maintaining tis-
sue architecture by killing cells not properly bound to their
underlying matrix, is also inhibited in L6 myoblasts and in
human colonocytes (Ordoñez et al., 2000). These results in-
dicate that the findings in the L6 model system also apply
to more biomedically relevant systems. In further support
of this suggestion, we have recently shown that the CEA
GPI anchor interacts with a molecular system common to
all of these pleiotrophic and multiple system effects. Thus,
recent evidence indicates perturbation of the function and/
or regulation of specific integrin ECM receptors as the un-
derlying cause of the inhibition of both differentiation and
anoikis by CEA and CEACAM6 in L6 myoblasts, P19 EC
cells, and human colonocytes (Ordoñez, C., R.A. Screaton,
C. Ilantzis, M. Fan, L. DeMarte, and C.P. Stanners, manu-
script submitted for publication; Malette, B., and C.P. Stan-
ners, manuscript submitted for publication).
 
The CEA GPI Anchor Is Required to
Inhibit Differentiation
 
A summary of the results of the domain-exchange experi-
ments between CEA, CEACAM1, and NCAM is shown
Figure 6. NCAM p125, N–C, and N–C blunt
constructs are GPI-linked. (Top left) Immu-
noblots showing equivalent volumes of cold
Triton X-100 soluble (S) and insoluble (P)
fractions from L6 transfectants expressing
NCAM, N–C, and N–C blunt. Monolayer L6
myoblast cultures producing NCAM and N–C
and LR-73 fibroblast cultures producing N–C
blunt were treated with PI-PLC before immu-
nostaining with anti–human NCAM mAb,
and analyzed by FACS to detect residual cell
surface expression. Profiles for control L6 and
LR-73 Neo vector-only transfectant cultures
are included to indicate levels of background
labeling.Screaton et al. Role of CEA GPI Anchor in Differentiation Block 621
in Fig. 9. The GPI-linked CEACAM1 chimera, C1–C, in-
hibited differentiation, indicating that CEA extracellular
sequences can be functionally substituted by those of
CEACAM1, provided they have the GPI linkage of CEA.
Importantly, the reciprocal construct, a TM-linked CEA,
C–C1S, allowed fusion to proceed, confirming that the ex-
tracellular domains of CEA alone are insufficient to in-
hibit differentiation and demonstrating that CEA retains
this function only when GPI anchored. C–C1S can medi-
ate homotypic intercellular adhesion (Fig. 4), demonstrat-
ing that CEA extracellular domains do not require the
GPI anchor for self binding.
The p125 isoform of human NCAM is a GPI-linked Ig
superfamily member that mediates homotypic intercellu-
lar adhesion through its third IgC domain (Siu, C.-H., per-
sonal communication). NCAM p125, unlike CEA and
CEACAM6, accelerates fusion in L6 myoblasts (Fig. 7 and
Screaton, R.A., and C.P. Stammers, unpublished observa-
tions), as in C2 myoblasts (Peck and Walsh, 1993), indicat-
ing the specificity of the CEA effect. The high degree of
homology between the adhesion domains of CEA and
CEACAM1 (.70%) could have accounted for the ability
of CEACAM1 extracellular domains to substitute for those
of CEA in the C1–C construct. The most highly related
amino acid sequences of NCAM and CEA, however, show
,30% homology (NCAM 3, 4, and 5, versus CEA B1-
A2-B2 IgC domains). Thus, it is intriguing that replacing
the COOH-terminal GPI signal sequence of NCAM with
that of CEA converts NCAM into a differentiation-inhib-
iting molecule. NCAM sequences provide a homotypic ad-
hesion function when attached to the CEA GPI signal se-
quence (Fig. 4), allowing NCAM extracellular domains to
substitute for CEA extracellular domains. Given that the
extracellular sequences from CEA, CEACAM1, and NCAM
can all contribute to the differentiation inhibition phenotype,
we conclude that any sequence able to confer homotypic
adhesion is required, but that the specificity for the inhibi-
tion of differentiation resides in the specific GPI anchor of
CEA. By extension, the latter specificity would also reside
in the GPI anchor determined by CEACAM6 (Fig. 9).
Figure 7. Inhibition of myogenic differentiation requires the specific GPI-determining COOH-terminal domain of CEA. Photomicro-
graphs of neo, CEA, NCAM p125, and N–C and N–C blunt L6 transfectant cultures incubated for 4 d in differentiation medium. Neo
and NCAM cultures differentiate into myotubes in differentiation medium, whereas CEA, N–C, and N–C blunt transfectants remain as
single cell populations. Thus, acquisition of the COOH-terminal domain of CEA by NCAM p125 converts NCAM into a differentia-
tion-blocking protein.The Journal of Cell Biology, Volume 150, 2000 622
GPI Anchors as Gain of Function Structures
Aside from the biological specificity observed here in dif-
ferent GPI anchors derived from different COOH-termi-
nal domains, there is precedent for the fact that the mode
of membrane linkage (GPI versus TM) per se can affect
protein function. Thus, the cellular isoform of the prion
protein requires a GPI signal sequence for conversion to
the infectious scrapie isoform; a TM form not targeted to
rafts cannot adopt the pathogenic conformation (Kaneko
et al., 1997). GPI functional dependency has also been re-
ported for the folate receptor (Wang et al., 1996), murine
DAF (Song et al., 1996), and the lymphocyte surface anti-
gens Qa-2 and Ly6 (Robinson et al., 1989; Su et al., 1991).
Replacing the GPI anchor of Qa-2 and Ly-6 with a TM se-
quence abrogates their ability to stimulate T cell activa-
tion, whereas replacing the TM domain of the signaling
incompetent H-2 protein with a GPI anchor from Qa-2
generates a signaling-competent protein. In some cases,
GPI/TM anchor exchange has no measurable effect on
function, as shown for CD14 and tissue factor (Lee et al.,
1993; Paborsky et al., 1991). Our data provides additional
evidence that a GPI membrane attachment can be a gain
of function structure.
Membrane Localization May Explain Opposite Effects 
of TM and GPI CEA Family Members
Extensive evidence suggests that asymmetries in lipid
composition in cell surface membranes can affect localiza-
tion of membrane proteins, exemplified by the mutual af-
finity of sphingolipids/cholesterol found in raft domains
and the highly saturated lipid components of the GPI an-
chor itself (Simons and Ikonen, 1997). We propose that
the ability of the GPI-linked CEA family members to in-
hibit differentiation stems from changes in the repertoire
of membrane elements available for interaction due to
altered membrane localization. Neither CEACAM1 nor
C–C1S, both TM proteins, inhibit myogenesis, and both are
soluble in cold Triton X-100 (Fig. 3), suggesting that the
TM domain guides these proteins into an area of the mem-
brane distinct from the GPI-anchored proteins under in-
vestigation. Interestingly, the localization of the TM pro-
tein influenza virus hemagglutinin in rafts is dependent on
specific amino acid residues found in the exoplasmic half
of the membrane-spanning region, residues expected to be
in contact with DIG lipids (Scheiffele et al., 1997). How-
ever, apical targeting of hemagglutinin in epithelial cells
requires these same residues as well as residues towards
the COOH-terminal end of the TM domain (Lin et al.,
1998).
How does CEA, lacking proteinaceous intracellular
domains, transmit information leading to biological re-
sponses? The colocalization and coimmunopurification of
GPI proteins, second messengers, and src-family kinases
in membrane rafts, areas which generally exclude TM pro-
teins, has suggested a localization-dependent mechanism
whereby GPI proteins may participate in signaling (Brown,
1993; Malek et al., 1994). In hematopoietic systems, cross-
linking of GPI proteins results in calcium mobilization,
cytokine production/release, and proliferative activity (Rob-
Figure 8. GPI-linked NCAM and CEA are in different plasma membrane domains in L6 transfectants. L6 myoblasts coexpressing CEA
and NCAM were analyzed for their surface staining pattern by immunofluorescence after fixation with paraformaldehyde (a and b) or
before fixation with (c and d) and without (e and f) patching. Both NCAM and CEA coalesce to form patches when cross-linked with
antibodies. However, NCAM is not patched by antibody-induced cross-linking of CEA (c and d), and vice versa (e and f).Screaton et al. Role of CEA GPI Anchor in Differentiation Block 623
inson, 1991). Cross-linking of cell surface CEA in rat baso-
philic leukemia transfectant cells can elicit protein tyrosine
phosphorylation of intracellular targets via src-family ki-
nases, events which require the GPI anchor (Dráber, P.,
and C.P. Stanners, unpublished results). The requirement
for cross-linking suggests that aggregation of GPI proteins
into high molecular weight complexes containing their sig-
naling partners is a prerequisite for signaling, as has been
demonstrated for exogenous DAF ‘painted’ (by exogenous
addition) into U937 cell surface membranes (van den Berg
et al., 1995).
Specific Raft Domains?
The above considerations pertain to changes in protein
function resulting from TM/GPI exchanges. We show here
that there exists specificity conferred by the GPI anchor of
CEA that is not present in the GPI anchor of NCAM,
even where both are attached to the same external do-
main. How could two proteins, functionally distinguish-
able only by their GPI anchors, send specific signals, even
those eliciting opposite cellular responses? Evidence pre-
sented here that CEA and NCAM p125 could be localized
to different rafts in L6 cells could be interpreted to indi-
cate that there are distinct raft domains that are able to se-
lectively concentrate different GPI proteins. (As men-
tioned in Results, this interpretation depends on the
assumption that the clustering forces mediated by the anti-
bodies did not pull truly colocalized CEA and NCAM
p125 molecular complexes apart.) A consequence of selec-
tive localization would be that CEA, through interactions
with signaling components unique to a specific membrane
subdomain, could elicit distinct responses from other GPI
proteins, e.g., NCAM. Therefore, biological specificity
could be determined by differences in the membrane mi-
croenvironment in which the GPI anchor is found. The re-
cent demonstration in living cells that GPI proteins exclu-
sively reside in submicron scale domains, z70 nm in
diameter, that contain from 15 to 50 GPI-anchored mole-
cules (Friederichson and Kurzchalia, 1998; Varma and
Mayor, 1998), suggests that two different GPI proteins
may be found in separate compartments at the cell surface.
Contrary to our results with CEA and NCAM, Harder
et al. (1998) demonstrated that the GPI proteins PLAP
and Thy-1 copatch at the surface of BHK cells when simul-
taneously cross-linked. However, only variable copatching
was seen when one protein was patched alone before
staining of the second—a result which was attributed to
hindered accessibility of antibody against the second anti-
gen, presumed already to be in the patches. We would oth-
erwise interpret these observations as additional evidence
of unique raft domains.
Do Individual GPI Anchors Possess Specific
Biological Information?
The ability of the COOH-terminal sequence of CEA to
confer the differentiation-blocking activity to CEACAM1
Figure 9. Schematic diagram of CEA family,
NCAM 125, and chimeric constructs and their
effect on myogenic differentiation. GPI mem-
brane anchors of CEA (black) and NCAM
125 (white) are shown as circles; the six mem-
brane proximal extracellular amino acid resi-
dues of CEA that are present in C1–C and
N–C are depicted above the construct sche-
matics. The membrane-spanning and cyto-
plasmic domains of C1–4L and C1–1S (as part
of C–C1S construct) are shown as narrow
open bars. CEA family member extracellular
C2 set Ig domains known to be involved in
homophilic adhesion are shown in gray. The
NH2-terminal and internal domains of CEA
family members are highly related and are
identical in length but are not identical in se-
quence; this is depicted by different shading.
The NCAM (and N–C and N–C blunt) extra-
cellular Ig domains are highly divergent from
those of the CEA family; the adhesion do-
main, Ig3, is dotted.The Journal of Cell Biology, Volume 150, 2000 624
and NCAM poses two questions: first, is there information
in the structure of GPI anchors themselves which is capa-
ble of conferring specific biological function? Second, how
could specific information found in GPI anchors be deter-
mined by the COOH-terminal hydrophobic sequence?
For the latter, it is possible that the signal sequence at the
extreme COOH terminus directs the protein to a specific
GPI transamidase activity in the ER, which in turn directs
selective modification of the anchor, or that the signal se-
quence determines the timing of such modifications re-
sulting in changes to their extent. Regarding the former
question, GPI anchors vary in the number and specific
composition of additional glycan side chains which may be
appended to the core anchor glycan structure (Lisanti et
al., 1990). Different glycoforms of the GPI anchor on two
NCAM isoforms in C2 myoblasts have been found (Mukasa
et al., 1995), indicating that different anchor constituents
can coexist in the same cell. GPI anchors of DAF and ace-
tylcholinesterase are commonly modified by acylation of
the inositol ring, which makes them resistant to PI-PLC
treatment (Roberts et al., 1988; Walter et al., 1990). Inter-
estingly, whether or not DAF is inositol acylated depends
on the cellular context, suggesting that different cells can
attach different anchors to the same protein precursor
(Walter et al., 1990). Possibly an unknown substitution
(mannosylation, ethanolamine, lipid modification) of the
CEA anchor itself could confer specific information. Con-
trolled release of GPI proteins by PI-PLC or PI-PLD would
produce free membrane-bound GPIs, which are known to
act as hormone-induced second messengers in cell signal-
ing processes (Gaulton and Pratt, 1994). Moreover, a free
GPI toxin from the malarial parasite Plasmodium initiates
a protein tyrosine phosphorylation cascade that induces
the upregulation of ICAM1, VCAM1, and E-selectin in
endothelial cells (Schofield et al., 1996). The CEA effect
on differentiation appears to depend on information pro-
vided by the adhesion property of the molecule, however,
suggesting that the mechanism of inhibition involves more
than a cleavage product of the CEA anchor. Alternatively,
the adhesion function may serve to increase the local con-
centration of CEA before a cleavage event, resulting in a
greater impact of the released anchor on signaling. GPI
proteins that act as cellular receptors are endocytosed
through caveolae, microinvaginations of the plasma mem-
brane, which may serve as focal points to effect a higher
local concentration of ligand. In conclusion, there is ample
precedent for significant secondary modifications in GPI
anchors that could determine which membrane micro-
domains they associate with, thereby determining their bi-
ological specificity.
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